Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 12/20 | 0.45 |
| ▸ | NAMPT | P43490 | 5/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24408911 | 0.88 | POLB (0.50) | GPR119NAMPTPOLBOPRD1OPRK1 | |
| SCHEMBL24408910 | 0.85 | GPR119 (0.47) | GPR119NAMPT | |
| SCHEMBL29634699 | 0.83 | ACACB (0.35) | HRH3 | |
| SCHEMBL22520476 | 0.80 | GPR119 (0.52) | GPR119NAMPTHRH3 | |
| SCHEMBL13161934 | 0.80 | POLB (0.48) | GPR119NAMPTPOLBOPRD1OPRK1 | |
| SCHEMBL29634691 | 0.77 | GPR119 (0.54) | GPR119NAMPTHRH3 | |
| SCHEMBL24408939 | 0.76 | GPR119 (0.47) | GPR119NAMPTHRH3 | |
| SCHEMBL17848653 | 0.76 | GPR119 (0.54) | GPR119HRH3 | |
| SCHEMBL31094899 | 0.76 | GPR119 (0.54) | GPR119HRH3 | |
| SCHEMBL24408862 | 0.76 | POLB (0.49) | GPR119POLBOPRD1OPRK1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022095971-A1 | SPIRO HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海医药集团股份有限公司 | 2022-05-12 | — | — | WO | disclosed |
| WO-2022095971-A1 | SPIRO HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海医药集团股份有限公司 | 2022-05-12 | — | — | WO | disclosed |